Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
作者信息
McHale M S, Velez-Garcia E, Nelson O, Williams S D, Maddox W, Birch R
出版信息
Cancer Treat Rep. 1986 Jul;70(7):925-6.
PMID:3521849
Abstract
摘要
相似文献
1
Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
Cancer Treat Rep. 1986 Jul;70(7):925-6.
2
Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Cancer Treat Rep. 1986 Apr;70(4):529-30.
3
Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
Cancer Treat Rep. 1987 Apr;71(4):425-6.
4
Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
Cancer Treat Rep. 1986 Jun;70(6):799-800.
5
Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
Cancer Treat Rep. 1986 Aug;70(8):1039-40.
6
[Dibromodulcitol in combination with actinotherapy of spinocellular carcinoma].
Sb Lek. 1984 Sep;86(8-9):259-64.
7
Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Cancer Treat Rep. 1984 Mar;68(3):559-60.
8
Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
Cancer Treat Rep. 1984 Feb;68(2):427-8.
9
Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Cancer Treat Rep. 1983 Jan;67(1):91-2.
10
Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
Cancer Treat Rep. 1985 Jan;69(1):125-6.
Zotero 插件